Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet‐induced obesity

Dendritic cell immunoreceptor 2 (DCIR2) deficiency decreases hepatic conventional dendritic cell content but not the progression of diet‐induced obesity

Abstract Aims Inflammatory pathways and immune system dysregulation participate in the onset and progression of cardiometabolic diseases. The dendritic cell immunoreceptor 2 (DCIR2) is a C‐type lectin receptor mainly expressed by conventional type 2 dendritic cells, involved in antigen recognition a...

Descripció completa

Dades bibliogràfiques
Autors principals:	Rossella Bellini, Annalisa Moregola, Jasmine Nour, Patrizia Uboldi, Fabrizia Bonacina, Giuseppe D. Norata
Format:	Article
Idioma:	English
Publicat:	Wiley 2023-10-01
Col·lecció:	Immunity, Inflammation and Disease
Matèries:	Clec4a4 C‐type lectin receptors DCIR2 dendritic cells obesity
Accés en línia:	https://doi.org/10.1002/iid3.1024

Ítems similars

Dendritic cell marker Clec4a4 deficiency limits atherosclerosis progression
per: Rossella Bellini, et al.
Publicat: (2023-03-01)

Skin Delivery of Clec4a Small Hairpin RNA Elicited an Effective Antitumor Response by Enhancing CD8+ Immunity In Vivo
per: Tzu-Yang Weng, et al.
Publicat: (2017-12-01)

Ligand binding and signaling of dendritic cell immunoreceptor (DCIR) is modulated by the glycosylation of the carbohydrate recognition domain.
per: Karien Bloem, et al.
Publicat: (2013-01-01)

Characterization of the Porcine CLEC12A and Analysis of Its Expression on Blood Dendritic Cell Subsets
per: Belén Álvarez, et al.
Publicat: (2020-05-01)

Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1
per: Lennon Ramos Pereira, et al.
Publicat: (2020-10-01)

Dendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitors.
per: Alexandra A Lambert, et al.
Publicat: (2013-01-01)

DNGR-1, a Dendritic Cell-Specific Sensor of Tissue Damage That Dually Modulates Immunity and Inflammation
per: Francisco J. Cueto, et al.
Publicat: (2020-02-01)

STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells
per: Fernando Bandeira Sulczewski, et al.
Publicat: (2021-01-01)

Crosstalk between dendritic cells and T lymphocytes during atherogenesis: Focus on antigen presentation and break of tolerance
per: Rossella Bellini, et al.
Publicat: (2022-07-01)

A replication study confirms the association of dendritic cell immunoreceptor (DCIR) polymorphisms with ACPA - negative RA in a large Asian cohort.
per: Jianping Guo, et al.
Publicat: (2012-01-01)

The consequences of multiple simultaneous C-type lectin-ligand interactions: DCIR alters the endo-lysosomal routing of DC-SIGN
per: Juan J. eGarcia-Vallejo, et al.
Publicat: (2015-03-01)

Correction: A Replication Study Confirms the Association of Dendritic Cell Immunoreceptor (DCIR) Polymorphisms with ACPA - Negative RA in a Large Asian Cohort.
per: Jianping Guo, et al.
Publicat: (2012-01-01)

Stories From the Dendritic Cell Guardhouse
per: J. Kenneth Hoober, et al.
Publicat: (2019-12-01)

Correlation of CLEC1B haplotypes with plasma levels of soluble CLEC-2 in healthy individuals
per: Mani Etemad, et al.
Publicat: (2021-11-01)

Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
per: Christian H. K. Lehmann, et al.
Publicat: (2016-03-01)

DCIR3 and DCIR4 are widely expressed among tissue-resident macrophages with the exception of microglia and alveolar macrophages
per: Ryo Okada, et al.
Publicat: (2020-12-01)

Clec9a-Mediated Ablation of Conventional Dendritic Cells Suggests a Lymphoid Path to Generating Dendritic Cells In Vivo
per: Johanna Salvermoser, et al.
Publicat: (2018-04-01)

The structure of CLEC-2: mechanisms of dimerization and higher-order clustering
per: Eleyna M Martin, et al.
Publicat: (2021-08-01)

The diagnostic role of C2PAC index in cases of sepsis-induced coagulopathy (SIC)
per: Mohamed Shaaban Mousa, et al.
Publicat: (2023-10-01)

C-type lectin receptors in skin immunity: Emerging new role for CLEC12B
per: Lauriane Blot, et al.
Publicat: (2022-01-01)

Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation
per: Fabrizia Bonacina, et al.
Publicat: (2018-08-01)

DCIR suppresses osteoclastic proliferation and resorption by downregulating M-CSF and RANKL signaling
per: Tomonori Kaifu, et al.
Publicat: (2023-05-01)

Harnessing human cross-presenting CLEC9A+XCR1+ dendritic cells for immunotherapy
per: Kirsteen eTullett, et al.
Publicat: (2014-05-01)

Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells
per: Jack D Chan, et al.
Publicat: (2020-01-01)

SARS-CoV-2 receptor ACE2 is upregulated by fatty acids in human MASH
per: Luis Cano, et al.
Publicat: (2024-01-01)

Development and Characterization of Nanobodies Targeting the Kupffer Cell
per: Fang Zheng, et al.
Publicat: (2021-02-01)

C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice
per: Ryohei Yokomori, et al.
Publicat: (2023-12-01)

Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer
per: Che-Yuan Hu, et al.
Publicat: (2023-09-01)

The C-type lectin DCIR contributes to the immune response and pathogenesis of colorectal cancer
per: Giulia Trimaglio, et al.
Publicat: (2024-03-01)

The Snake Venom Rhodocytin from Calloselasma rhodostoma— A Clinically Important Toxin and a Useful Experimental Tool for Studies of C-Type Lectin-like Receptor 2 (CLEC-2)
per: Øyvind Bruserud
Publicat: (2013-04-01)

CLEC2 and CLEC5A: Pathogenic Host Factors in Acute Viral Infections
per: Pei-Shan Sung, et al.
Publicat: (2019-12-01)

CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation
per: Ranodeep Chatterjee, et al.
Publicat: (2023-12-01)

Corrigendum: CLEC12A sensitizes differentially responsive breast cancer cells to the anti-cancer effects of artemisinin by repressing autophagy and inflammation
per: Ranodeep Chatterjee, et al.
Publicat: (2024-03-01)

Leishmania donovani Attenuates Dendritic Cell Trafficking to Lymph Nodes by Inhibiting C-Type Lectin Receptor 2 Expression via Transforming Growth Factor-β
per: Manisha Yadav, et al.
Publicat: (2023-06-01)

CLEC4E upregulation in gastric cancer: A potential therapeutic target correlating with tumor-associated macrophages
per: Qin Jiang, et al.
Publicat: (2024-03-01)

CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment
per: Yinjiang Zhang, et al.
Publicat: (2021-08-01)

A case-control study on correlation between the single nucleotide polymorphism of CLEC4E and the susceptibility to tuberculosis among Han people in Western China
per: Wenjing Zhou, et al.
Publicat: (2021-08-01)

Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update
per: Urban Švajger, et al.
Publicat: (2018-10-01)

The Dynamics of Dendritic Cell—Mediated Innate Immune Regulation
per: Toshiaki Ohteki
Publicat: (2007-01-01)

Epithelial Cell-Associated Galectin-3 Activates Human Dendritic Cell Subtypes for Pro-Inflammatory Cytokines
per: John T. Schroeder, et al.
Publicat: (2020-10-01)